Natural Lock Acetabular Component
510(k) K830662
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK830662 | Date11 Apr 1983 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JDL
- Device Class
- Class III
- Regulation
- 21 CFR Part 888.3320
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Natural Lock Acetabular Component is a Prosthesis, Hip, Semi-Constrained (Metal Cemented Acetabular Component). This device is designed to replace the damaged or diseased acetabulum in total hip arthroplasty, providing a stable, metal-backed socket for femoral components to articulate with. Its semi-constrained design offers enhanced stability while maintaining natural joint motion, making it suitable for primary and revision hip replacements.
This component is supplied as a reusable medical device and is intended for use in orthopedic surgical settings. It is not sterile at the time of shipment but is sterilized prior to surgical use, adhering to standard orthopedic implant protocols. The device is classified as Class III under FDA regulations and holds FDA 510K clearance (K830662) with a Traditional clearance pathway. Multiple registration numbers (e.g., 8043792, 2242737) and FEI numbers (e.g., 3020282716) correspond to its authorized variants, ensuring compliance with 21 CFR 888.3320 for hip prostheses.
Other devices from Advanced Biosearch Assn.
Questions
AI-generated answers, 18 Sep 2026
Is the Natural Lock Acetabular Component designed for primary or revision hip replacements, and how does its semi-constrained design benefit patients?
The Natural Lock Acetabular Component is approved for both primary and revision total hip arthroplasty. Its semi-constrained design provides enhanced stability compared to fully unconstrained sockets while still allowing for natural joint motion, which helps reduce dislocation risks in patients with compromised soft tissue support or complex anatomy.
How is the Natural Lock Acetabular Component sterilized before surgical use, and is it supplied sterile at the time of shipment?
The device is not sterile at shipment but is sterilized prior to surgical use following standard orthopedic implant protocols. Since it is reusable, sterilization is performed in the surgical setting using validated methods like ethylene oxide or autoclaving, ensuring safety for repeated use.
Are there multiple sizes or models available for the Natural Lock Acetabular Component, and how does this affect its versatility in surgery?
While the provided data lists multiple registration numbers and FEI codes (e.g., 3020282716, 1000577893), the exact sizes or models are not specified. However, the presence of numerous registration numbers suggests a range of variants to accommodate different patient anatomies, improving versatility for both primary and revision cases.
What regulatory pathway was used for FDA clearance, and how does this affect its compliance and use in clinical settings?
The Natural Lock Acetabular Component received FDA clearance through the Traditional 510(k) pathway (K830662) with a Substantially Equivalent (SESE) decision. This means it was compared to a legally marketed predicate device and deemed equivalent in safety and effectiveness, ensuring compliance with 21 CFR 888.3320 for hip prostheses. Clinically, this clearance confirms its adherence to FDA standards for orthopedic implants.